CASI Pharmaceuticals
CASI
#10378
Rank
HK$33.37 M
Marketcap
HK$1.62
Share price
0.00%
Change (1 day)
-90.67%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$21.61

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.68. In 2024 the company made an earnings per share (EPS) of -HK$20.04 a decrease over its 2023 EPS that were of -HK$15.81.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$21.617.85%
2024-HK$20.0426.73%
2023-HK$15.81-32.89%
2022-HK$23.5611.9%
2021-HK$21.05-38.44%
2020-HK$34.20-8.96%
2019-HK$37.5750%
2018-HK$25.0577.78%
2017-HK$14.095.88%
2016-HK$13.31-22.73%
2015-HK$17.22-76.09%
2014-HK$72.01318.18%
2013-HK$17.22-71.79%
2012-HK$61.0565.96%
2011-HK$36.79-50%
2010-HK$73.57-18.97%
2009-HK$90.79-63.64%
2008-HK$249.673.57%
2007-HK$241.06-60.56%
2006-HK$611.2797.22%
2005-HK$309.94-2.7%
2004-HK$318.55-45.59%
2003-HK$585.44-61.8%
2002-HK$1,532-25.52%
2001-HK$2,058-21.38%
2000-HK$2,61713.86%
1999-HK$2,299149.53%
1998-HK$921.2098.15%
1997-HK$464.9110.2%
1996-HK$421.86